1. Long-term survival of pancreatic cancer patients treated with multimodal therapy combined with WT1-targeted dendritic cell vaccines
   Shuichi Hanada et al, 2019, Human Vaccines & Immunotherapeutics CrossRef
2. Clinical Significance of Tumor-Infiltrating T Cells and Programed Death Ligand-1 in Patients with Pancreatic Cancer
   Sayumi Yoshida et al, 2019, Cancer Investigation CrossRef
3. Predicted Markers of Overall Survival in Pancreatic Cancer Patients Receiving Dendritic Cell Vaccinations Targeting WT1
   Zensho Ito et al, 2019, Oncology CrossRef
4. Baseline immunity predicts prognosis of pancreatic cancer patients treated with WT1 and/or MUC1 peptide-loaded dendritic cell vaccination and a standard chemotherapy
   Shuichi Ota et al, 2024, Human Vaccines & Immunotherapeutics CrossRef
5. Reader‑free ELISPOT assay for immuno‑monitoring in peptide‑based cancer vaccine immunotherapy
   Sae Hayashi et al, 2020, Biomedical Reports CrossRef